Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedThe study page adds an Amyloidosis topic and a Genetic and Rare Diseases Information Center resource, along with a new citation for a 2026 JAMA Cardiol article. A previously listed JAMA Cardiol article reference was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check110 days agoChange DetectedShow glossary option added; Brno-střed, Czechia added as a location. QC-related text updated (Last Update Submitted that Met QC Criteria) and the revision shows v3.4.0, with capitalization changes for No FEAR Act Data.SummaryDifference0.1%

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.